— Know what they know.
Not Investment Advice

ATRY.MC BME

Atrys Health, S.A.
1W: -4.8% 1M: +3.2% 3M: +0.4% YTD: -12.5% 1Y: -9.2% 3Y: -42.3% 5Y: -76.0%
€2.58 ($2.88)
-0.04 (-1.72%)
 
Weekly Expected Move ±5.8%
€2 €2 €3 €3 €3
BME · Healthcare · Biotechnology · Tech Score Sell · Power 51 · €195.5M mcap · 40M float · 0.132% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market Cap€195.5M ($218.8M)
52W Range2.31-3.59
Volume55,005
Avg Volume52,747
Beta0.57
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOMarian Isach
Employees763
SectorHealthcare
IndustryBiotechnology
IPO Date2016-07-22
Calle VelAzquez, 24
Madrid, CT 28002
ES
34 91 781 94 65
About Atrys Health, S.A.

Atrys Health, S.A., a biomedical enterprise founded in 2007 and based in Madrid, Spain, specializes in providing a range of diagnostic services and medical treatments. Its diagnostic portfolio encompasses areas like pathology, hematology, molecular pathology, and genetics, supplemented by offerings such as diagnostic second opinions, a comprehensive test directory, and support for clinical trials and research & development. The company effectively utilizes telemedicine to deliver its expertise in medical specialties including radiology, cardiology, ophthalmology, and dermatology. Furthermore, Atrys Health administers radiotherapy and is engaged in the development of innovative therapeutic approaches and diagnostic instruments. The organization operated as Althia Health, S.L. before rebranding to Atrys Health, S.A. in May 2016.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms